Table 4.

Baseline and post-intervention measures of health-related quality of life.

Variable	Exercise group (n = 9)			Control group (n = 8)			F; p value	MD [95% CI]	F; p value
Mean ± SD	Baseline	Post-intervention	MD [95% CI]	Baseline	Post-intervention	MD [95% CI]	Within-group	Between-group	Between-group
HRQoL (SF-36)
PCSa	46 ± 6	48 ± 8	2 [−3 to 6]	42 ± 5	40 ± 9	−2 [−7 to 2]	0.0; 0.89	4 [−2 to 10]	1.80; 0.20
MCSa	55 ± 6	51 ± 14	−4 [−12 to 5]	46 ± 6	51 ± 8	5 [−2 to 12]	0.1; 0.80	−8 [−18 to 2]	3.2; 0.10
Physical functioninga	67 ± 14	74 ± 18	7 [−4 to 18]	52 ± 24	55 ± 23	3 [−8 to 13]	2.1; 0.16	5 [−9 to 19]	0.5; 0.49
Role physicala	72 ± 23	69 ± 38	−3 [−22 to 17]	44 ± 14	44 ± 17	0 [−16 to 16]	0.1; 0.81	−3 [−27 to 21]	0.1; 0.81
Bodily paina	62 ± 12	60 ± 26	−2 [−26 to 22]	63 ± 23	56 ± 33	−8 [−34 to 19]	0.4; 0.54	6 [−27 to 38]	0.1; 0.71
General healtha	72 ± 19	72 ± 26	0 [−15 to 14]	63 ± 19	65 ± 21	3 [−13 to 18]	0.1; 0.80	−3 [−22 to 16]	0.1; 0.73
Vitalitya	67 ± 18	72 ± 30	−5 [−10 to 20]	52 ± 17	54 ± 17	2 [−7 to 10]	0.7; 0.41	3 [−13 to 20]	0.2; 0.67
Social functioninga	78 ± 22	74 ± 35	−4 [−21 to 13]	69 ± 22	73 ± 29	5 [−15 to 25]	0.0; 0.96	−9 [−33 to 15]	0.6; 0.45
Role emotionala	88 ± 17	80 ± 29	−8 [−31 to 14]	57 ± 20	68 ± 22	10 [−10 to 31]	0.0; 0.88	−19 [−47 to 9]	2.0; 0.18
Mental healtha	80 ± 14	73 ± 24	−7 [−23 to 9]	70 ± 18	79 ± 17	9 [−3 to 20]	0.1; 0.81	−15 [−34 to 3]	3.2; 0.09
HRQoL (FACT-L)
Physical well-beinga	25 ± 2	24 ± 5	−1 [−4 to 3]	22 ± 5	21 ± 7	−1 [−4 to 2]	0.9; 0.36	0 [−4 to 4]	0.0; 0.91
Social/family well-beinga	20 ± 8	21 ± 7	0 [−4 to 4]	15 ± 9	19 ± 6	4 [1 to 8]	3.7; 0.07	−4 [−9 to 1]	3.3; 0.09
Emotional well-beinga	21 ± 2	19 ± 6	−2 [−5 to 1]	18 ± 5	20 ± 4	2 [−1 to 5]	0.0; 0.95	−4 [−8 to 1]	3.6; 0.08
Functional well-beinga	20 ± 5	21 ± 9	2 [−3 to 6]	13 ± 7	17 ± 8	4 [−5 to 12]	1.8; 0.20	−2 [−11 to 6]	0.3; 0.59
Lung cancer subscalea	20 ± 3	22 ± 4	3 [0 to 5]	16 ± 2	20 ± 3	5 [1 to 8]	16.3; 0.01	−2 [−6 to 2]	1.0; 0.33
Totala	106 ± 16	107 ± 25	2 [−10 to 14]	83 ± 22	97 ± 21	13 [−1 to 28]	3.6; 0.08	−12 [−29 to 5]	2.2; 0.16
HRQoL (EORTC QLQ-C30)
Global health statusa	74 ± 16	75 ± 25	1 [−22 to 24]	66 ± 24	64 ± 22	−2 [−10 to 6]	0.0; 0.91	3 [−20 to 27]	0.1; 0.79
Functional scalesa	85 ± 9	85 ± 17	0 [−10 to 11]	73 ± 16	76 ± 12	3 [−3 to 9]	0.3; 0.57	−3 [−14 to 9]	0.2; 0.63
Symptoms scalesb	20 ± 9	17 ± 13	−3 [−15 to 8]	22 ± 11	23 ± 15	1 [−8 to 10]	0.1; 0.77	−4 [−18 to 9]	0.4; 0.52
EORTC LC13b	16 ± 8	14 ± 8	−2 [−10 to 6]	16 ± 9	25 ± 19	9 [−1 to 19]	1.5; 0.23	−11 [−23 to 1]	3.8; 0.07

CI, confidence interval; EORTC QLQ-C30, The European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire Core 30; EORTC LC13, Lung Cancer subscale of the EORTC QLQ-C30; FACT-L, The Functional Assessment of Cancer Therapy – Lung scale; MCS, mental component score; MD, mean difference; PCS, physical component score; SD, standard deviation; SF-36, Medical Outcomes Study Short-Form 36 general health survey.

^aGreater scores reflect better outcome.

^bLower scores reflect better outcome.